Patents by Inventor Kurt Swanson

Kurt Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220332767
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 20, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Andrea CARFI
  • Publication number: 20220213177
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: December 29, 2021
    Publication date: July 7, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • Publication number: 20220119457
    Abstract: This disclosure relates to antigenic multimeric respiratory syncytial virus (RSV) G polypeptides for use in eliciting an immune response to RSV.
    Type: Application
    Filed: September 29, 2021
    Publication date: April 21, 2022
    Applicant: Sanofi
    Inventors: Kurt Swanson, Chih-Jen Wei, Gary J. Nabel
  • Patent number: 11261239
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: March 1, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • Publication number: 20210269489
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: May 7, 2021
    Publication date: September 2, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Andrea CARFI
  • Publication number: 20210113681
    Abstract: Ferritin proteins comprising a mutation replacing a surface-exposed amino acid with a cysteine, an N- or C-terminal linker comprising a cysteine, and/or one or more immune-stimulatory moieties linked to the ferritin protein via a surface-exposed amino acid are disclosed. The ferritin proteins can further comprise a non-ferritin polypeptide and be antigenic, e.g., for use in eliciting antibodies against the non-ferritin polypeptide.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 22, 2021
    Applicant: SANOFI
    Inventors: Gary J. Nabel, Chih-Jen Wei, Kurt Swanson
  • Publication number: 20210017237
    Abstract: This disclosure relates to antigenic respiratory syncytial virus (RSV) polypeptides for use in eliciting antibodies against RSV. Also disclosed are antigenic polypeptides comprising an RSV polypeptide and a ferritin protein.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicant: Sanofi
    Inventors: Gary J. Nabel, Chih-Jen Wei, Kurt Swanson, Pradeep Dhal, Ram Dharanipragada, Magnus Besev
  • Publication number: 20210015896
    Abstract: This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicant: Sanofi
    Inventors: Gary J. Nabel, Chih-Jen Wei, Laura Nguyen, Kurt Swanson, Te-Hui Chou, Stefan Koester
  • Publication number: 20210017238
    Abstract: This disclosure relates to antigenic OspA polypeptides and their use in eliciting antibodies against OspA. Also disclosed are antigenic polypeptides comprising an OspA polypeptide and a ferritin protein.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicant: Sanofi
    Inventors: Gary J. Nabel, Chih-Jen Wei, Heather Kamp, Ronnie Wei, Kurt Swanson
  • Patent number: 10716288
    Abstract: An enrichment device for dispensing edible food products to an animal, and including the capability to provide the animals meal with said device. The device includes a body, an upper surface which preferably is removable from the body, a cavity, at least one passageway in the upper surface, the passageway communicating with the cavity to allow food to pass from the upper surface into the cavity. The body has a wall forming the cavity, and the wall has one or more openings therein to allow for food to pass from the cavity outside of the device where it may be consumed by the animal. The device bottom is configured to provide a rocking motion when the device is disrupted.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: July 21, 2020
    Assignee: CURIO HOLDING COMPANY
    Inventors: Dennis P. O'Donnell, Eric Griffin, Keith Hatton, John Combs, Kurt Swanson, Devin Sidell
  • Publication number: 20200172600
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: August 16, 2017
    Publication date: June 4, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • Publication number: 20180237476
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: October 20, 2017
    Publication date: August 23, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Kurt SWANSON, Andrea CARFI
  • Publication number: 20170127648
    Abstract: An enrichment device for dispensing edible food products to an animal, and including the capability to provide the animals meal with said device. The device includes a body, an upper surface which preferably is removable from the body, a cavity, at least one passageway in the upper surface, the passageway communicating with the cavity to allow food to pass from the upper surface into the cavity. The body has a wall forming the cavity, and the wall has one or more openings therein to allow for food to pass from the cavity outside of the device where it may be consumed by the animal The device bottom is configured to provide a rocking motion when the device is disrupted.
    Type: Application
    Filed: September 16, 2016
    Publication date: May 11, 2017
    Applicant: Clear-Coat Holding Company
    Inventors: Dennis P. O'Donnell, Eric Griffin, Keith Hatton, John Combs, Kurt Swanson, Devin Sidell
  • Publication number: 20150329597
    Abstract: Complexes that contain RSV F ectodomain polypeptides and methods for making the complexes are disclosed. The RSV F ectodomain polypeptides can be in the prefusion form.
    Type: Application
    Filed: November 19, 2013
    Publication date: November 19, 2015
    Inventors: Andrea CARFI, Kurt SWANSON
  • Publication number: 20140248314
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: May 14, 2012
    Publication date: September 4, 2014
    Applicant: NOVARTIS AG
    Inventors: Kurt Swanson, Andrea Carfi
  • Patent number: D812133
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: March 6, 2018
    Assignee: Lux Products Corporation
    Inventors: Kurt Swanson, Alexander McAuley
  • Patent number: D842712
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: March 12, 2019
    Assignee: Johnson Controls, Inc.
    Inventors: Kurt Swanson, Devin Sidell, Alexander McAuley, Gary Hsieh, Robert S. Munin
  • Patent number: D853053
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: July 2, 2019
    Inventors: Dennis P. O'Donnell, Eric Griffin, Keith Hatton, John Combs, Kurt Swanson, Devin Sidell
  • Patent number: D875569
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: February 18, 2020
    Assignee: Johnson Controls, Inc.
    Inventors: Kurt Swanson, Devin Sidell, Alexander McAuley, Gary Hsieh, Robert Munin
  • Patent number: D884288
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: May 12, 2020
    Assignee: CURIO HOLDING COMPANY
    Inventors: Dennis P. O'Donnell, Eric Griffin, Keith Hatton, John Combs, Kurt Swanson, Devin Sidell, John James Stone